Chargement en cours...

Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies

Phenotypic rather than genotypic tests remain the gold standard for diagnosing glucose-6-phosphate dehydrogenase (G6PD) deficiency. However, with increasing use of genomic arrays and whole exome or genome sequencing, G6PD genetic data are increasingly available. We examined the utility of G6PD genet...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharmacogenomics J
Auteurs principaux: Robinson, Katherine M., Yang, Wenjian, Haidar, Cyrine E., Hankins, Jane S., Jay, Dennis W., Kornegay, Nancy, Rubnitz, Jeffrey E., Broeckel, Ulrich, Cheng, Cheng, Pui, Ching-Hon, Jeha, Sima, Relling, Mary V.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6414283/
https://ncbi.nlm.nih.gov/pubmed/30206300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41397-018-0043-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!